Regenerative Medical Technology Group Inc. (RMTG)
OTCMKTS · Delayed Price · Currency is USD
0.0300
+0.0020 (7.14%)
Aug 1, 2025, 4:00 PM EDT

Accolade Statistics

Total Valuation

RMTG has a market cap or net worth of 376,169. The enterprise value is 19.21 million.

Market Cap376,169
Enterprise Value 19.21M

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date Aug 14, 2025
Ex-Dividend Date n/a

Share Statistics

RMTG has 12.54 million shares outstanding. The number of shares has increased by 0.67% in one year.

Current Share Class 12.54M
Shares Outstanding 12.54M
Shares Change (YoY) +0.67%
Shares Change (QoQ) -0.00%
Owned by Insiders (%) 8.63%
Owned by Institutions (%) 4.32%
Float 10.92M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.08
PB Ratio -0.01
P/TBV Ratio n/a
P/FCF Ratio 0.58
P/OCF Ratio 0.47
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 35.19, with an EV/FCF ratio of 29.85.

EV / Earnings -4.40
EV / Sales 4.13
EV / EBITDA 35.19
EV / EBIT 54.87
EV / FCF 29.85

Financial Position

The company has a current ratio of 0.05

Current Ratio 0.05
Quick Ratio 0.04
Debt / Equity n/a
Debt / EBITDA 36.74
Debt / FCF 31.17
Interest Coverage 0.07

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) 6.20%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -1.35%
Revenue Per Employee 4.65M
Profits Per Employee -4.36M
Employee Count 1
Asset Turnover 1.32
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -53.63% in the last 52 weeks. The beta is -0.13, so RMTG's price volatility has been lower than the market average.

Beta (5Y) -0.13
52-Week Price Change -53.63%
50-Day Moving Average 0.04
200-Day Moving Average 0.04
Relative Strength Index (RSI) 40.45
Average Volume (20 Days) 69,110

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.01

Income Statement

In the last 12 months, RMTG had revenue of 4.65 million and -4.36 million in losses. Loss per share was -0.35.

Revenue4.65M
Gross Profit 3.20M
Operating Income 350,171
Pretax Income -4.36M
Net Income -4.36M
EBITDA 545,972
EBIT 350,171
Loss Per Share -0.35
Full Income Statement

Balance Sheet

The company has 1.22 million in cash and 20.06 million in debt, giving a net cash position of -18.84 million or -1.50 per share.

Cash & Cash Equivalents 1.22M
Total Debt 20.06M
Net Cash -18.84M
Net Cash Per Share -1.50
Equity (Book Value) -28.12M
Book Value Per Share -2.24
Working Capital -28.43M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 799,842 and capital expenditures -156,265, giving a free cash flow of 643,577.

Operating Cash Flow 799,842
Capital Expenditures -156,265
Free Cash Flow 643,577
FCF Per Share 0.05
Full Cash Flow Statement

Margins

Gross margin is 68.70%, with operating and profit margins of 7.52% and -93.71%.

Gross Margin 68.70%
Operating Margin 7.52%
Pretax Margin -93.71%
Profit Margin -93.71%
EBITDA Margin 11.73%
EBIT Margin 7.52%
FCF Margin 13.83%

Dividends & Yields

RMTG does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.67%
Shareholder Yield n/a
Earnings Yield -1,159.58%
FCF Yield 171.09%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on September 26, 2018. It was a reverse split with a ratio of 0.001.

Last Split Date Sep 26, 2018
Split Type Reverse
Split Ratio 0.001

Scores

RMTG has an Altman Z-Score of -31.13 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -31.13
Piotroski F-Score 6